Yes, and this is one of the most important clinical conversations I have with families at Vatsalya Hospital, Varanasi, because well-controlled disease on medication and the question of whether to pursue immunotherapy are not mutually exclusive. They represent two fundamentally different levels of ambition in allergy treatment. Medication, when taken correctly and consistently, can control allergy and asthma symptoms effectively. A child on an inhaled corticosteroid, a nasal steroid spray, and an antihistamine may have no episodes and function normally. This is a successful outcome by the standard of symptom management. But the medication is doing something specific: it is suppressing the inflammatory consequences of an immune response that continues unchanged. Every pollen season, every exposure to house dust mite, every contact with the specific allergen, the same immune reaction occurs, and the medication manages its effects. Stop the medication, and the symptoms return. Immunotherapy is a different ambition. The goal is to change the immune response itself: to train the immune system to tolerate the specific allergen rather than react against it, so that over time the body encounters that allergen without triggering the allergic cascade at all. This is why immunotherapy is the only treatment in allergy described as disease-modifying. The clinical reasons to consider immunotherapy even in a well-controlled child include: the wish to reduce or eliminate the need for ongoing daily medication and its associated cost and inconvenience; the opportunity to prevent the natural history of allergic disease from advancing, since allergic rhinitis can progress to asthma in a proportion of untreated children, and immunotherapy is one of the few interventions shown to reduce this progression; and the desire for lasting benefit beyond the treatment period rather than symptom control that ends when the medication is stopped. The practical consideration is the commitment: three to five years of regular injections or daily drops at home. The conversation about whether to pursue immunotherapy is one I am happy to have in detail at Vatsalya Hospital, Varanasi, and the answer depends on the specific child, their allergen profile, and what the family's goals for treatment are.
Related reading:
Allergen Immunotherapy for Children: How It Works, Who It Helps, and What the Treatment Involves
Childhood Asthma: A Complete Guide to Diagnosis, Treatment, and Long-Term Control
Pediatric Allergy and Asthma: Symptoms, Causes, and Care Tips
Pediatric and Neonatal Pulmonology: Breathing Life into Healthy Childhood
Written by Dr. Divyank Pathak, MBBS, MD (Paediatrics), IFPCCM, DPAA, FNPP, DPSM, FAAP, Director and Senior Consultant Paediatrician, Pediatric Critical Care and Allergy and Asthma Specialist, Vatsalya Superspeciality Children Hospital, Varanasi 221002. Phone: +91 9838713111.
